Patient perspectives on factors influencing active surveillance adherence for low-risk prostate cancer: A qualitative study

被引:1
|
作者
Subramanian, Lalita [1 ]
Hawley, Sarah T. [1 ,2 ]
Skolarus, Ted A. [2 ,3 ]
Rankin, Aaron [1 ]
Fetters, Michael D. [4 ]
Witzke, Karla [5 ]
Chen, Jason [1 ]
Radhakrishnan, Archana [1 ,2 ,6 ]
机构
[1] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[2] VA Ann Arbor Healthcare Syst, Ctr Clin Management Res, Hlth Serv Res & Dev, Ann Arbor, MI USA
[3] Univ Chicago, Dept Surg, Urol Sect, Chicago, IL USA
[4] Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA
[5] MyMichigan Hlth, Dept Urol, Midland, MI USA
[6] Univ Michigan, Dept Internal Med, Div Gen Med, Internal Med, Ann Arbor, MI 48109 USA
来源
CANCER MEDICINE | 2024年 / 13卷 / 01期
关键词
active surveillance; primary care physicians; prostate cancer; quality of life; trust; urologists; MEN; CRITERIA;
D O I
10.1002/cam4.6847
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundProstate cancer is the most common cancer among men in the United States. Treatment guidelines recommend active surveillance for low-risk prostate cancer, which involves monitoring for progression, to avoid or delay definitive treatments and their side effects. Despite increased uptake, adherence to surveillance remains a challenge.MethodsWe conducted semi-structured, qualitative, virtual interviews based on the Theoretical Domains Framework (TDF), with men (15) who were or had been on active surveillance for their low-risk prostate cancer in 2020. Interviews were transcribed and coded under TDF's behavioral theory-based domains. We analyzed domains related to adherence to surveillance using constructivist grounded theory to identify themes influencing decision processes in adherence.ResultsThe TDF domains of emotion, beliefs about consequences, environmental context and resources, and social influences were most relevant to surveillance adherence-. From these four TDF domains, three themes emerged as underlying decision processes: trust in surveillance as treatment, quality of life, and experiences of self and others. Positive perceptions of these three themes supported adherence while negative perceptions contributed to non-adherence (i.e., not receiving follow-up or stopping surveillance). The relationship between the TDF domains and themes provided a theoretical process describing factors impacting active surveillance adherence for men with low-risk prostate cancer.ConclusionsMen identified key factors impacting active surveillance adherence that provide opportunities for clinical implementation and practice improvement. Future efforts should focus on multi-level interventions that foster trust in surveillance as treatment, emphasize quality of life benefits and enhance patients' interpersonal experiences while on surveillance to optimize adherence. Decision processes related to staying on or stopping active surveillance for prostate cancer involved trust in active surveillance as treatment, quality of life and experiences of self and others. Positive perceptions of these three themes supported adherence while negative perceptions contributed to non-adherence.image
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Intensity of Active Surveillance and Transition to Treatment in Men with Low-risk Prostate Cancer
    Olsson, Henrik
    Nordstrom, Tobias
    Clements, Mark
    Gronberg, Henrik
    Lantz, Anna Wallerstedt
    Eklund, Martin
    EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (05): : 640 - 647
  • [42] Prospective quality-of-life outcomes for low-risk prostate cancer: Active surveillance versus radical prostatectomy
    Jeldres, Claudio
    Cullen, Jennifer
    Hurwitz, Lauren M.
    Wolff, Erika M.
    Levie, Katherine E.
    Odem-Davis, Katherine
    Johnston, Richard B.
    Pham, Khanh N.
    Rosner, Inger L.
    Brand, Timothy C.
    L'Esperance, James O.
    Sterbis, Joseph R.
    Etzioni, Ruth
    Porter, Christopher R.
    CANCER, 2015, 121 (14) : 2465 - 2473
  • [43] Active surveillance for low-risk bladder cancer
    Tiu, Albert
    Jenkins, Lawrence C.
    Soloway, Mark S.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) : 33.e7 - 33.e10
  • [44] Active surveillance in men with low-risk prostate cancer: current and future challenges
    Han, Christopher Sejong
    Parihar, Jaspreet Singh
    Kim, Isaac Yi
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2013, 1 (01): : 72 - 82
  • [45] Active surveillance for low-risk prostate cancer: selection of patients and predictors of progression
    Dall'Era, Marc A.
    Konety, Badrinath R.
    NATURE CLINICAL PRACTICE UROLOGY, 2008, 5 (05): : 277 - 283
  • [46] A Systematic Approach to Discussing Active Surveillance with Patients with Low-risk Prostate Cancer
    Ehdaie, Behfar
    Assel, Melissa
    Benfante, Nicole
    Malhotra, Deepak
    Vickers, Andrew
    EUROPEAN UROLOGY, 2017, 71 (06) : 866 - 871
  • [47] Active surveillance for low-risk prostate cancer: diversity of practice across Europe
    Azmi, A.
    Dillon, R. A.
    Borghesi, S.
    Dunne, M.
    Power, R. E.
    Marignol, L.
    O'Neill, B. D. P.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 (02) : 305 - 311
  • [48] Active surveillance for low-risk prostate cancer in Austria: the online registry of the Qualitatspartnerschaft Urologie (QuapU)
    Eredics, Klaus
    Dorfinger, Karl
    Kramer, Gero
    Ponholzer, Anton
    Madersbacher, Stephan
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 (11-12) : 375 - 379
  • [49] New Histopathological & Genetic Features to Improve Active Surveillance Selection for Low-Risk Prostate Cancer
    Chu, Kevin
    Corcoran, Niall
    Norden, Sam
    Wong, Lih-Ming
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2018, 18 (07) : 951 - 957
  • [50] A single centre experience of active surveillance as management strategy for low-risk prostate cancer in Ireland
    Forde, J. C.
    Daly, P. J.
    White, S.
    Morrin, M.
    Smyth, G. P.
    O'Neill, B. D. P.
    Power, R. E.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2014, 183 (03) : 377 - 382